• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Biocon Limited — Important, 18-08-2026: Updates

    18-08-2026 | 08:40 am

    Biocon's US subsidiary secured FDA approval for Yesintek® (ustekinumab-kfce) single-dose autoinjectors. This new delivery format expands patient treatment options for autoimmune diseases, significantly strengthening Biocon's immunology presence in the US market.

    No comments yet. Be the first to comment!

    All announcements from Biocon Limited